Reference:
  1. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363: 139-149.
  2. Yew HS, Murdoch DR. Global trends in infective endocarditis epidemiology. Curr Infect Dis Rep 2012;14(4):367-72.
  3. Hoen B, Duval X. Clinical practice. Infective endocarditis. N Eng J Med 2013;368(15):1425-33.
  4. Sande MA, Anderson KM. Infective endocarditis. In: Fuster V, Alexander RW, O’Rourke RA, editors. Hurst’s the heart. 10th ed. New York: McGraw-Hill 2002;2087-125.
  5. François D. Is early surgery beneficial in infective endocarditis? A systematic review. Arch Cardiovasc Dis 2011;104(1):35-44.
  6. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012;366(26):2466-73.
  7. Osler W. Galstonian lectures on malignant endocarditis. Lancet 1885;1:415–418;459-464;505–508.
  8. Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One 2013;8(12):e82665.
  9. Damasco PV, Ramos JN, Correal JC, Potsch MV, Vieira VV, Camello TC, et al. Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals. Infection 2014;42(5):835-42.
  10. Nunes MC, Gelape CL, Ferrari TC. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis 2010;14(5):e394-8.
  11. Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998–2013. JAMA 2017;5;317(16):1652-1660.
  12. Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al; Association pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group. Changing profle of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288(1):75-81.
  13. Ferreiros E, Nacinovich F, Casabe´ JH, Modenesi JC, Swieszkowski S, Cortes C, et al; EIRA-2 Investigators. Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The endocarditis infecciosa en la República Argentina-2 (EIRA-2) Study. Am Heart J 2006;151(2):545-52.
  14. Watt G, Pachirat O, Baggett HC, Maloney SA, Lulitanond V, Raoult D, et al. Infective endocarditis in northeastern Thailand. Emerg Infect Dis 2014;20(3):473-6.
  15. Xu H, Cai S, Dai H. Characteristics of infective endocarditis in a tertiary hospital in East China. PLoS ONE 2016;11(11):e0166764.
  16. Gupta A, Kaul U, Varma A. Infective endocarditis in an Indian setup: are we entering the ‘modern’era? Indian J Crit Care Med 2013;17(3):140-7.
  17. Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Dreser A, Leufkens HG, Wirtz VJ. Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS One 2013;8(10):e75550.
  18. Sucutu M, Davutoglu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia region. Arch Turk Soc Cardiol 2010;38(2):107-11.
  19. Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, Sinha N. Characteristics of infective endocarditis in a developing country—clinical profile and outcome in 192 Indian patients, 1992–2001. Int J Cardiol 2005;98(2):253-60.
  20. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345(18):1318-30.
  21. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler Jr VG, Bayer AS, et al; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169(5):463-73.
  22. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al . A systematic review of population-based studies of infective endocarditis. Chest 2009;132(3):1025-35.
  23. Sunil M, Hieu HQ, Arjan Singh RS, Ponnampalavanar S, Siew KSW, Loch A. Evolving trends in infective endocarditis in a developing country: a consequence of medical progress? Ann Clin Microbiol Antimicrob 2019;18(1):43.
  24. Sy RW, kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 2010;31(15):1890-7.
  25. Selton-Suty C, Ce´lard M, Le Moing V, Doco-Lecompte, Chirouze C, Lung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1 year population based survey. Clin Infect Dis 2012;54(9):1230-9.
  26. Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg 2016;22(3):336-45.
  27. Kanafani ZA, Kanj SS, Cabell CH, Cecchi E, de Oliveira Ramos A, Lejko-Zupanc T,  et al. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. Eur J Clin Microbiol Infect Dis 2010;29(10):1203-10.
  28. Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis 2011;11:48.
  29. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36(44):3075-3128.
Table 1. Baseline Characteristics